CVS Health Corporation $CVS Shares Acquired by Alps Advisors Inc.

Key Points

• Alps Advisors increased its CVS Health stake by 12.4% in the third quarter, adding 34,573 shares to reach 313,027 shares valued at about $26.8 million.
• Executive Vice President Prem Shah bought 23,855 shares for roughly $2 million, increasing his stake by 36.9%.
• CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, but its planned business separation has raised concerns about execution and value.

Alps Advisors Inc. lifted its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 12.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 313,027 shares of the pharmacy operator's stock after acquiring an additional 34,573 shares during the quarter. Alps Advisors Inc.'s holdings in CVS Health were worth $26,823,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Kilter Group LLC purchased a new position in shares of CVS Health during the 2nd quarter valued at approximately $27,000. Beaird Harris Wealth Management LLC increased its position in shares of CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock valued at $30,000 after purchasing an additional 195 shares during the period. J.Safra Asset Management Corp bought a new position in CVS Health in the second quarter worth $30,000. Timbuktu Capital Management LLC bought a new position in CVS Health in the second quarter valued at $31,000. Finally, Dunhill Financial LLC acquired a new position in CVS Health during the second quarter valued at approximately $32,000. 80.66% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Prem Shah purchased 23,855 shares of CVS Health stock in a transaction dated Friday, November 6th. The shares were acquired at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the transaction, the executive vice president owned 88,516 shares of the company's stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.85% of the company's stock.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Stock Up 3.0%

CVS Health stock opened at $83.76 on Friday. The firm has a fifty day moving average price of $90.37 and a two-hundred day moving average price of $88.89. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The firm has a market cap of $107.12 billion, a price-to-earnings ratio of 11.29, a P/E/G ratio of 0.82 and a beta of 0.58.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, beating the consensus estimate of $1.65 by $0.44. The company had revenue of $108.40 billion during the quarter, compared to analysts' expectations of $104.72 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.60 EPS. As a group, analysts forecast that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were issued a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Thursday, October 22nd. CVS Health's dividend payout ratio is currently 30.97%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on CVS shares. TD Cowen restated a "buy" rating on shares of CVS Health in a report on Wednesday. Robert W. Baird set a $107.00 price target on CVS Health in a research report on Thursday, August 6th. JPMorgan Chase & Co. raised their target price on CVS Health from $111.00 to $118.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 12th. Jefferies Financial Group reissued a "buy" rating and set a $103.00 price target on shares of CVS Health in a report on Wednesday. Finally, Truist Financial boosted their price objective on shares of CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Twenty-two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $108.25.

About CVS Health

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.